Someone who is recovering from drug addiction is trying to get back on their feet.  But what if the medication that is supposed to help is causing problems? 

In this episode of David v. Goliath, hosts Matt Dolman and Stan Gipe discuss the newest emerging mass tort relating to the use of Suboxone, a medication commonly prescribed to individuals with opioid addiction to help them get off of opiates. Recent findings show that the sublingual film version of Suboxone is acidic and causes the degradation of the protective outer layer of teeth and tooth enamel. This can have a cataclysmic effect on people’s lives, and even impact their ability to find employment. 

There's currently a group of about 40 lawsuits in different districts throughout the United States that are likely to be consolidated over the next few weeks into multidistrict litigation (MDL). The Judicial Panel on Multidistrict Litigation (JPML) meets on January 25th and a steering committee will be selected by late February. In the meantime, anyone who has experienced dental problems while taking Suboxone before 2022, may be able to recover compensation and should contact a reputable attorney. For more information on the Suboxone Tooth Decay Lawsuit, visit the Dolman Law Group website.

Learn More and Connect

☑️ Matt Dolman | LinkedIn

☑️ Stan Gipe

☑️ Dolman Law Group

☑️ Dolman Law Group on LinkedIn, Facebook, Instagram, YouTube

☑️ Subscribe: Apple Podcasts | Spotify | Google Podcasts | YouTube

The insights and views presented in this podcast are for general information purposes only and should not be taken as legal advice for any individual case or situation. The information presented is not a substitute for consulting with an attorney. Nor does tuning in to this podcast constitute an attorney-client relationship of any kind. Any case result information provided on any portion of this podcast should not be understood as a promise of any particular result in a future case. Dolman Law Group Accident Injury Lawyers: Big firm results, small firm personal attention.